REBLOZYL

Trademark Status LIVE
Expiration 29.06.2027

Application

United Kingdom

2024-09-11

3.347.297™

UK APP

00003240555

29.06.2017

Classes

Текст Текст Текст View in office

Owner

Celgene Corporation

Registrator

Sipara Limited

Classes

05

NICE Classification

  • Pharmaceutical preparations for use in the treatment of beta thalassemia and myelodsplatic syndromes, autoinflammatory disease, autoimmune disease, blood disease, cancer, arthritis, musculoskeletal and skin diseases in the fields of oncology, immunology and inflammation;
    pharmaceutical preparations, namely, cytokine inhibitory drugs;
    pharmaceutical preparations that modulate the immune system.;

Domain names similar "REBLOZYL"

Are you an IP company?

Contact us to learn how to improve your business by cutting your costs, and engaging new customers

Trademark catalog